118 related articles for article (PubMed ID: 24343096)
1. Characterization of metal profiles in serum during the progression of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Metallomics; 2014 Feb; 6(2):292-300. PubMed ID: 24343096
[TBL] [Abstract][Full Text] [Related]
2. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.
Gerhardsson L; Lundh T; Minthon L; Londos E
Dement Geriatr Cogn Disord; 2008; 25(6):508-15. PubMed ID: 18463412
[TBL] [Abstract][Full Text] [Related]
3. Homeostasis of metals in the progression of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Biometals; 2014 Jun; 27(3):539-49. PubMed ID: 24668390
[TBL] [Abstract][Full Text] [Related]
4. Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease.
Bomboi G; Marchione F; Sepe-Monti M; De Carolis A; Bianchi V; Medda E; Pino A; Bocca B; Forte G; D'Ippolito C; Giubilei F
Ann Ist Super Sanita; 2005; 41(2):205-12. PubMed ID: 16244394
[TBL] [Abstract][Full Text] [Related]
5. Characterization of plasma metal profiles in Alzheimer's disease using multivariate statistical analysis.
Guan C; Dang R; Cui Y; Liu L; Chen X; Wang X; Zhu J; Li D; Li J; Wang D
PLoS One; 2017; 12(7):e0178271. PubMed ID: 28719622
[TBL] [Abstract][Full Text] [Related]
6. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
Greenough MA; Camakaris J; Bush AI
Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of element profile changes induced by long-term dietary supplementation of zinc in the brain and cerebellum of 3xTg-AD mice by alternated cool and normal plasma ICP-MS.
Ciavardelli D; Consalvo A; Caldaralo V; Di Vacri ML; Nisi S; Corona C; Frazzini V; Sacchetta P; Urbani A; Di Ilio C; Sensi SL
Metallomics; 2012 Dec; 4(12):1321-32. PubMed ID: 23151739
[TBL] [Abstract][Full Text] [Related]
8. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
[TBL] [Abstract][Full Text] [Related]
9. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
Basun H; Forssell LG; Wetterberg L; Winblad B
J Neural Transm Park Dis Dement Sect; 1991; 3(4):231-58. PubMed ID: 1772577
[TBL] [Abstract][Full Text] [Related]
10. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease, metal ions and metal homeostatic therapy.
Zatta P; Drago D; Bolognin S; Sensi SL
Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
[TBL] [Abstract][Full Text] [Related]
12. Brain biometals and Alzheimer's disease - boon or bane?
Prakash A; Dhaliwal GK; Kumar P; Majeed AB
Int J Neurosci; 2017 Feb; 127(2):99-108. PubMed ID: 27044501
[TBL] [Abstract][Full Text] [Related]
13. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier.
Nischwitz V; Berthele A; Michalke B
Anal Chim Acta; 2008 Oct; 627(2):258-69. PubMed ID: 18809082
[TBL] [Abstract][Full Text] [Related]
14. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
[TBL] [Abstract][Full Text] [Related]
15. Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis.
Alimonti A; Ristori G; Giubilei F; Stazi MA; Pino A; Visconti A; Brescianini S; Sepe Monti M; Forte G; Stanzione P; Bocca B; Bomboi G; D'Ippolito C; Annibali V; Salvetti M; Sancesario G
Neurotoxicology; 2007 May; 28(3):450-6. PubMed ID: 17267042
[TBL] [Abstract][Full Text] [Related]
16. Distinctive Pattern of Serum Elements During the Progression of Alzheimer's Disease.
Paglia G; Miedico O; Cristofano A; Vitale M; Angiolillo A; Chiaravalle AE; Corso G; Di Costanzo A
Sci Rep; 2016 Mar; 6():22769. PubMed ID: 26957294
[TBL] [Abstract][Full Text] [Related]
17. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
[TBL] [Abstract][Full Text] [Related]
18. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Data on the Interaction between Some Biometals and Oxidative Stress Status in Mild Cognitive Impairment and Alzheimer's Disease Patients.
Balmuș IM; Strungaru SA; Ciobica A; Nicoara MN; Dobrin R; Plavan G; Ștefănescu C
Oxid Med Cell Longev; 2017; 2017():7156928. PubMed ID: 28811866
[TBL] [Abstract][Full Text] [Related]
20. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
